A chronic condition characterized by high levels of glucose in the blood. There are two main types: Type 1, caused by the destruction of insulin-producing cells in the pancreas, and Type 2, caused by the body's inability to effectively use insulin. Both types can lead to serious health complications if left untreated. Individuals with diabetes need to monitor their blood glucose levels regularly. Adequate control of diabetes leads to a lower risk of complications associated with unmonitored diabetes including kidney failure (requiring dialysis or transplant), blindness, heart disease, and limb amputation.
| Brand | SKU | Compositions | Therapy Area |
| Sitawow | Sitawow 50 | Sitagliptin 50 mg | Antidiabetics |
| Sitawow 100 | Sitagliptin 100 mg | ||
| Sitawow M 50/500 | Sitagliptin 50 mg + Metformin 500 mg | ||
| Sitawow M 50/1000 | Sitagliptin 50 mg + Metformin 1000 mg | ||
| Sitawow M 100/500 | Sitagliptin 100 mg + Metformin (Prolonged Release) 500 mg | ||
| Affodapa | Affodapa 5 | Dapagliflozin 5 mg | |
| Affodapa 10 | Dapagliflozin 10 mg | ||
| Affodapa S 5/50 | Sitagliptin 50 mg + Dapagliflozin 5 mg | ||
| Affodapa S 10/100 | Sitagliptin 100 mg + Dapagliflozin 10 Mg | ||
| Affodapa M 10/500 | Dapagliflozin 10 mg + Metformin 500 mg | ||
| Affodapa M 10/1000 | Dapagliflozin 10mg + Metformin 1000mg | ||
| Affodapa SM 500 | Dapagliflozin 10mg + Sitagliptin 100 mg + Metformin 500 mg | ||
| Affodapa SM 1000 | Dapagliflozin 10mg + Sitagliptin 100 + Metformin 1000 mg | ||
| Affodapa GM 1 | Dapagliflozin 10mg + Glimepiride 1 mg + Metformin 1000 mg | ||
| Affodapa GM 2 | Dapagliflozin 10mg + Glimepiride 2 mg+ Metformin 1000 mg | ||
| Repvog | Repvog 0.3/0.5 | Voglibose 0.3mg + Repaglinide 0.5mg | |
| Repvog 0.3/1 | Voglibose 0.3mg + Repaglinide 1 mg | ||
| Repvog 0.3/2 | Voglibose 0.3mg + Repaglinide 2 mg | ||
| MLRepa | MLRepa 0.5 | Repaglinide 0.5mg | |
| MLRepa 1 | Repaglinide 1 mg | ||
| MLRepa 2 | Repaglinide 2 mg | ||
| LGpin | LGpin | Linagliptin 5 mg | |
| LGpin-M 500 | Linagliptin 2.5 mg + Metformin 500 mg | ||
| LGpin-M 1000 | Linagliptin 2.5 mg + Metformin 1000 mg | ||
| LGpin-D | Linagliptin 5 mg + Dapagliflozin 10 mg |